Sethuraman Natarajan (CIK 1873394) reported 6 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-03). Recent activity: Sell TRDA (2,079 shares), Sell TRDA (25,907 shares), Buy TRDA (55,800 shares), Sell TRDA (3,898 shares), Sell TRDA (7,577 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-03 | Entrada Therapeutics, Inc. (TRDA) | President, Research & Develop. | Sell | 2,079 | $14,852 |
| 2026-05-04 | Entrada Therapeutics, Inc. (TRDA) | President, Research & Develop. | Sell | 25,907 | $398,709 |
| 2026-03-03 | Entrada Therapeutics, Inc. (TRDA) | President, Research & Develop. | Buy | 55,800 | $0 |
| 2026-03-03 | Entrada Therapeutics, Inc. (TRDA) | President, Research & Develop. | Sell | 3,898 | $45,451 |
| 2026-03-03 | Entrada Therapeutics, Inc. (TRDA) | President, Research & Develop. | Sell | 7,577 | $89,106 |
| 2025-09-04 | Entrada Therapeutics, Inc. (TRDA) | President, Research & Develop. | Sell | 1,760 | $9,557 |
Source: SEC Form 4 filings · as of 2026-09-03